Venkatesh A, Ma S, Punzo C
Department of Ophthalmology and Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Department of Neurobiology, University of Massachusetts Medical School, 386 Plantation Street, Worcester, MA 01605, USA.
Cell Death Dis. 2016 Jun 30;7(6):e2279. doi: 10.1038/cddis.2016.182.
Understanding the mechanisms that contribute to secondary cone photoreceptor loss in retinitis pigmentosa (RP) is critical to devise strategies to prolong vision in this neurodegenerative disease. We previously showed that constitutive activation of the mammalian target of rapamycin complex 1 (mTORC1), by loss of its negative regulator the tuberous sclerosis complex protein 1 (Tsc1; also known as Hamartin), was sufficient to promote robust survival of nutrient-stressed cones in two mouse models of RP by improving glucose uptake and utilization. However, while cone protection remained initially stable for several weeks, eventually cone loss resumed. Here we show that loss of Tsc1 in the cones of RP mice causes a defect in autophagy, leading to the accumulation of ubiquitinated aggregates. We demonstrate that this defect was not due to an inhibition of autophagy initiation, but due to an accumulation of autolysosomes, suggesting a defect in the end-stage of the process causing an amino-acid shortage in cones, thereby hampering long-term cone survival. Because cells with TSC loss fail to completely inhibit mTORC1 and properly activate autophagy in the absence of amino acids, we sporadically administered the mTORC1 inhibitor rapamycin, which was sufficient to correct the defects seen in cones, further enhancing the efficiency of cone survival mediated by Tsc1 loss. Concordantly, activation of mTORC1 by loss of the phosphatase and tensin homolog (Pten) did not affect autophagy and amino-acid metabolism, leading to a more sustained long-term protection of cones. As loss of Pten, which in cones results in less robust mTORC1 activation when compared with loss of Tsc1, still affords long-term cone survival, therapeutic interventions with mTORC1 activators or gene therapy with selected mTORC1 targets that improve glucose metabolism are potential strategies to delay vision loss in patients with RP.
了解导致色素性视网膜炎(RP)中继发性视锥光感受器丧失的机制对于制定延长这种神经退行性疾病患者视力的策略至关重要。我们之前表明,通过其负调节因子结节性硬化复合物蛋白1(Tsc1;也称为错构瘤蛋白)的缺失,哺乳动物雷帕霉素靶蛋白复合物1(mTORC1)的组成性激活足以通过改善葡萄糖摄取和利用来促进两种RP小鼠模型中营养应激视锥细胞的强劲存活。然而,虽然视锥细胞保护最初在数周内保持稳定,但最终视锥细胞丧失仍会恢复。在这里,我们表明RP小鼠视锥细胞中Tsc1的缺失导致自噬缺陷,导致泛素化聚集体的积累。我们证明这种缺陷不是由于自噬起始的抑制,而是由于自噬溶酶体的积累,这表明该过程终末期的缺陷导致视锥细胞中氨基酸短缺,从而阻碍视锥细胞的长期存活。由于在缺乏氨基酸的情况下,TSC缺失的细胞无法完全抑制mTORC1并正确激活自噬,我们间歇性地施用mTORC1抑制剂雷帕霉素,这足以纠正视锥细胞中出现的缺陷,进一步提高由Tsc1缺失介导的视锥细胞存活效率。与此一致,通过缺失磷酸酶和张力蛋白同源物(Pten)激活mTORC1并不影响自噬和氨基酸代谢,从而对视锥细胞产生更持久的长期保护。由于与Tsc1缺失相比,视锥细胞中Pten的缺失导致mTORC1激活较弱,但仍能实现视锥细胞的长期存活,因此用mTORC1激活剂进行治疗干预或用选定的改善葡萄糖代谢的mTORC1靶点进行基因治疗是延缓RP患者视力丧失的潜在策略。